Leprosy Mailing List Blog

Tuesday, November 4, 2025

Fw: Ref.: (LML) Introduction of Mrs Joëlle Kerl – Volunteer Mission in India

Leprosy Mailing List – November 4, 2025

Ref.: (LML) Introduction of Mrs Joëlle Kerl – Volunteer Mission in India

From: Laila de Laguiche, Curitiba, Brazil

Dear colleagues working in religious communities serving people affected by leprosy in India,

I hope this message finds you well.

I would like to introduce Mrs Joëlle Kerl, a French national who recently contacted me seeking advice on where she might volunteer for three months in India, in direct service to people living with leprosy.

During our conversation, Mrs Kerl deeply impressed me with her humanity, sensitivity, and strong empathy for patients. She has already volunteered in mobile clinics, assisting with screening and wound care — including complex dressings — always under nursing supervision.

She also brings extensive humanitarian experience across Africa, Madagascar, and India, where she previously worked in the leprosy centre of Rawthankuppam (Tamil Nadu). Her long career reflects a lifelong commitment to the most vulnerable, combining professionalism with deep compassion and respect.

Mrs Kerl will cover all her travel expenses and only requests accommodation and, if possible, meals during the period of her entirely voluntary service.

I would be most grateful if any of you could suggest a suitable community or institution that might welcome her. I would then be pleased to share your contact details with her.

Please find attached her detailed CV, which highlights a remarkable background in community health, development, and human rights.

Thank you very much for your kind attention and cooperation.

With my warmest regards and collegial friendship,

Dr Laila de Laguiche
Dermatologist – Leprologist
President, Alliance Against Leprosy (AAL)

________________________________________________________________________________

LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion visit https://groups.google.com/d/msgid/leprosymailinglist/46de4674-2ff7-453d-bd6a-0e6bf78519d9n%40googlegroups.com.

Fw: Ref.: (LML) 100% risk - multi-case families

Leprosy Mailing List �C November 4, 2025

Ref.: (LML) 100% risk - multi-case families

From: Joel Almeida, Mumbai, India

Note editor: Dear colleagues, I will be traveling till the first week of December. Nevertheless, your reactions or observations are always welcome.

_______________________________________________________________

Dear Pieter & colleagues,

We know that HD (Hansen Disease) can be manifested in as many as 60% of girls/women who are genetically susceptible (homozygous for an apparent major gene effect) as well as sufficiently exposed to the bacilli. (1) Nobody is aiming for 100% disease among girls/women. However, when physical signs of disease are found among all the girls/women in a household, and indeed when a household shows 100% cumulative incidence among all its members, it seems prudent to ask what is going on.

Typically bacilli enter the nasal epithelium with the aid of Mammalian Cell Entry protein 1A (2). Macrophages phagocytose the bacilli and eliminate them in a controlled and relatively harmless manner via mechanisms such as the vit D-induced cathelicidin system.(3) This elimination can be compromised if bacillary debris (eg. DNA) becomes available within the cytosol of macrophages, or if the concentration of bacilli is sufficiently high. (4) If macrophages with viable bacilli travel to perineural locations around the body, nerves can be damaged owing to PGL-1 mediated inducible Nitric Oxide Synthase (iNOS) and excessive NO levels that damage mitochondria in axons of peripheral nerves.(5) This can occur without any signs of inflammation (silent neuropathy). Skin signs can become detectable if melanocytes or cutaneous fibres are damaged. With aids such as high-resolution ultrasonography, nerve changes can be detected even before any signs appear in the skin. Where neglect is the rule, deformity can appear before HD is suspected.

The important lesson is that nerve function needs to be tested in all contacts of newly diagnosed patients. Further, nerve function needs to be monitored if there is any use of anti-microbials. Otherwise the bacillary debris within macrophages can activate the cGAS-STING pathway that results in OASL inhibition of the cathelicidin system, and reduced autophagy, allowing bacilli to replicate within macrophages and damaging nerves via PGL1 as noted above.

In a household where one or more individuals are shedding many bacilli in nasal discharges (6), it seems likely that all members of the household will have received bacilli in their nose or skin. If the vit D-induced cathelicidin system is allowed to do its job without interference, some or all of the infected persons will eliminate bacilli without suffering any harm, or at least will contain the bacilli in a non-replicating state within macrophages. If such persons are given chemoprophylaxis, the resulting bacillary debris in the cytosol will tend to move the macrophages to a permissive state where bacilli can replicate and cause nerve damage as described above. This can give rise to signs in the skin, anaesthesia, muscle weakness or even deformity.

Given the biology, it can be predicted that whereas formerly it was almost unheard of for more than 60% of girls/women in a household or village to develop signs of HD, this can be increased to 100% by the use of chemoprophylaxis among asymptomatic infected persons. 100% cumulative incidence has been reported in a family in Pekan, Pahang, Malaysia. (7) The pathological processes might take a few months or a few years, but they are predicted by the biology.

It seems prudent to warn family members and other contacts to refuse chemoprophylaxis, so as to reduce their risk of HD and its serious sequelae. Otherwise the biology predicts that we will see more multi-case famiilies, with some showing even multiple members with deformity developing silently before diagnosis. This is the exact reverse of what all of us wish to achieve.

With all sincerity,

Joel Almeida

References

1. Lázaro, F. P. et al. (2010) A major gene controls leprosy susceptibility in a hyperendemic isolated population from north of Brazil. J. Infect. Dis. 201(10), 1598�C1605

2.   Fadlitha VB, Yamamoto F, Idris I, Dahlan H, Sato N, Aftitah VB, et al. (2019) The unique tropism of Mycobacterium leprae to the nasal epithelial cells can be explained by the mammalian cell entry protein 1A. PLoS Negl Trop Dis 13(3): e0006704. https://doi.org/10.1371/journal. pntd.0006704

3.   da Silva Prata, et al. (2019) Macrophages in the Pathogenesis of Leprosy. DOI: http://dx.doi.org/10.5772/intechopen.88754

4.   de Toledo-Pinto et al (2016) STING-Dependent 2′-5′ Oligoadenylate Synthetase�CLike Production Is Required for Intracellular Mycobacterium leprae Survival. JID 214 :311-320

5. Madigan CA, Cambier CJ, Kelly-Scumpia et al (2017). A macrophage response to Mycobacterium leprae phenolic glycolipid initiates nerve damage in leprosy. Cell. 170(5):973-985. e10.

6. Davey TF, Rees RJ. The nasal discharge in leprosy: clinical and bacteriological aspects (1974). Lepr Rev. 45(2):121-34.

7. Benedict S et al (2025) Paucibacillary leprosy in a 6-month-old infant in an endemic area of Malaysia: a clinical case report. Lepr Rev (2025) 96, e2025074

________________________________________________________________________________

LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion visit https://groups.google.com/d/msgid/leprosymailinglist/1f81c194-eeff-47de-9933-c48d490f2c4en%40googlegroups.com.

Wednesday, October 22, 2025

Fw: Ref.: (LML) Infolep monthly overview of new publications on leprosy. October, 2025.

Leprosy Mailing List – 22 October, 2025

Ref.: (LML) Infolep monthly overview of new publications on leprosy. October, 2025.

From: Upasana Regmi and Elizabeth Talatu Williams, Amsterdam, the Netherlands

Dear colleagues,

We are pleased to share the October 2025 edition of the Infolep Newsletter, featuring the latest research, case studies, and global updates on leprosy and related topics.

This month's issue brings together a diverse selection of new publications and case reports on the wide dimensions of leprosy, from advances in diagnosis and treatment to ongoing challenges in stigma, disability, and inclusion.

Highlights include recent studies on immune response mechanisms, long-term complications, and cross-cultural validation of stigma assessment tools, as well as systematic reviews exploring quality of life and diagnostic innovations.

This month's news and events include key developments, inspiring stories, and several opportunities to stay engaged, from calls for papers and award nominations, such as the KV Desikan Memorial Award 2026, to upcoming events like the ASTMH Annual Meeting, ISNTD Water Conference, and the International Conference on Economic Inclusion for Persons with Disabilities.

Finally, we're delighted to welcome Elizabeth Talatu Williams, our new Infos Coordinator for Infolep and InfoNTD. With her strong background in knowledge sharing and public health communication, Elizabeth will be helping us strengthen connections across the leprosy and NTD communities.

We hope this collection will support your work, stimulate discussion, and provide useful resources for research, advocacy, and programmatic action. As always, we welcome your suggestions and contributions for future newsletters.

Please feel free to contact us if you would like access to full-text versions that are not available on Infolep, or if you would like our support with literature searches.

Warm wishes,
Upasana Regmi and Elizabeth Talatu Williams

www.leprosy-information.org
info@infolep.org

Featured Research Spotlight

Potential of the World Health Organization's Skin NTDs App to Support and Improve the Detection of Skin-Related Neglected Tropical Diseases: Protocol for a Performance Evaluation and Feasibility Study in Senegal
Sall D, Jockers D, Dioussé P, et al. JMIR Research Protocols. JMIR Publications Inc. 2025.

Challenges and Opportunities of Management of Long Term Complications of Persons Affected By Leprosy in Context of Integrated Program in Bangladesh.
Khan M, Ferdous J, Saadat M, et al. Mymensingh medical journal : MMJ. 2025; 34 (4) : 954-962.

Translation and cross-cultural validation of four tools for assessing stigma among community members and self-esteem among persons affected by leprosy in Nigeria
Murphy-Okpala N, Dahiru T, Ukwaja KN, et al. Leprosy Review. Lepra. 2025; 96 (3): 1-9.

Validation of the Hausa version of the EMIC-CSS and SDS among adults in Northern Nigeria
Dahiru T, Murphy-Okpala N, Abdullahi S, et al. Leprosy Review. Lepra. 2025; 96 (3): 1-10.

Cross-cultural validation of the Pidgin-English version of the EMIC-CSS and SDS among adults in Southern Nigeria
Nwafor C, Murphy-Okpala N, Eze C, et al. Leprosy Review. Lepra. 2025; 96 (3): 1-11.

New publications

Feel free to contact us to receive full-text versions if these cannot be found through the Infolep portal.

Addressing Pulmonary Embolism in Type 2 Lepra Reaction: A Call for Proactive Management
Thekho AJ, Mendiratta S, Mendiratta V, et al. Clinical Dermatology Review. Ovid Technologies (Wolters Kluwer Health). 2025; 9 (4): 386-388.

MoLEP—Co-creating a Mycobacterium leprae transmission interruption program for the Morogoro region, Tanzania
Barth-Jaeggi T, de Coulon G, Garimo I, et al. PLOS Neglected Tropical Diseases. Public Library of Science (PLoS). 2025; 19 (9): 1-9.

Voices from the margins: A qualitative study on the lived experiences of leprosy-affected individuals from two diverse rural communities in Malaysia
Abdul Rahman N, Rajaratnam V, Abdullah H, et al. SSM - Qualitative Research in Health. Elsevier BV. 2025.

Assessing the Feasibility of an Intensified Extended Contact Survey (IECS) Compared to Passive Household Screening for Leprosy in Bangladesh
Naher K, Rifat M, Biswas DK, et al. Tropical Medicine and Infectious Disease. MDPI AG. 2025; 10 (10): 1-9.

Endemicity, disability and neglect: Leprosy in Colombia 2007–2020
Arango-Úsuga C, Ochoa J, Hincapié-Palacio D, et al. PLOS Neglected Tropical Diseases. Public Library of Science (PLoS). 2025; 19 (9): 1-14.

Barriers to seeking healthcare services and contributing factors to grade 2 disability among women affected by leprosy in Telangana, India – a qualitative study
Nehring C, Kaifie A, Reddy A, et al. International Journal for Equity in Health. Springer Science and Business Media LLC. 2025; 24 (1): 1-14.

Epidemiologic characteristics of leprosy in Mainland China, 2004–2020
Yang Y, Zeng J, Li J. Frontiers in Public Health. Frontiers Media SA. 2025.

Tissue Expression of NGF in Skin Lesions of HIV-Coinfected and Non-Coinfected Leprosy Patients and Its Relationship with Leprosy Neural Damage
Xavier MB, Fontes LDS, Nascimento MGBD, et al. Microorganisms. MDPI AG. 2025; 13 (10): 1-15.

Leprosy still a concern in Eastern states of India: Primary care physician targeted approach needed.
Thangaraju P, Venkatesan S. Journal of family medicine and primary care. 2025; 14 (8):3598-3599.

Knowledge, Attitude, and Practices towards Leprosy among Nurses around Semarang, Indonesia
P R, PD K, A M, et al. Clinical Dermatology Open Access Journal. Medwin Publishers. 2025; 10 (1): 1-10.

Impact of protein prenylation inhibition on Mycobacterium leprae viability and IL-1ß production in infected macrophages
da Silva Rocha M, Rodrigues Pereira AM, Freire dos Santos PM, et al. Journal of Bacteriology. American Society for Microbiology. 2025; 207 (9): 1-17.

Demographic and clinical profile of leprosy patients in Lagos, Nigeria: a 17-year retrospective study
Cole-Adeife O, Dairo G, Agaga L, et al. Clinical and Experimental Dermatology. Oxford University Press (OUP). 2025.

Healthcare for Chronic Wound Management In Leprosy Patients
Babu SG, Anandaram H, P G, et al. 2025 International Conference on Next Generation Computing Systems (ICNGCS). IEEE. 2025.

Epidemiological profile of leprosy at the Hôpital de la Rive, City province of Kinshasa, Democratic Republic of Congo
Odimba Tundanonga R, Katabayi Mbiya A, Matshoko Limonge A, et al. Our Dermatology Online. Our Dermatology Online. 2025; 16 (Supp 3): 59-65.

TLR1/2-driven macrophage polarization shapes memory CD4+ T-cell responses across the leprosy spectrum
Chebli-de-Abreu N, Carvalho AMRS, Menezes YR, et al. Acta Tropica. Elsevier BV. 2025.

Evolução da Hanseníase em Mulheres no Piauí: O Que Mudou Entre 2014 e 2024?
Sá LRPFD, Queiroz PHDS, Santos RS, et al. Nursing Edição Brasileira. MPM Comunicacao. 2025; 30 (328): 11450-11473.

Desafios e enfrentamentos de residentes na avaliação de contatos de pacientes com hanseníase na Atenção Primária à Saúde em Palmas-TO
Soares de Sousa AK, da Silva Pimentel M, Antunes Paschoal Popolin M. Revista Cereus. Revista Cereus. 2025; 17 (3) : 43-58.

Ocular manifestations of leprosy in a tertiary health care centre in Northern India
Katoch S, Chandel T, Tuli R, et al. Leprosy Review. Lepra. 2025; 96 (3): 1-11.

Psychosocial Impact of Leprosy with and without Deformity
Khatu S, Deshpande SS, Jadhav S. Medical Journal of Dr. D.Y. Patil Vidyapeeth. Ovid Technologies (Wolters Kluwer Health). 2025; 18 (6): 991-996.

Editor's Choice – September 2025
Lepra. Leprosy Review. Lepra. 2025; 96 (3): 1-2.

Managing leprosy reactions with secukinumab: Insights from a case series.
Gomide L, Brufatto J, Kucarz T, et al. Revista da Sociedade Brasileira de Medicina Tropical. 2025.

Perceived Stigma Towards Person Affected by Leprosy Among Adult Living in Leprosy-endemic Areas in Keratong Sub-district, Pahang
Naem EH, Hashim SM, Osman M. Malaysian Journal of Medicine and Health Sciences. 2025.

Infrared Thermography for Detection of Neural Impairment in Leprosy: A Cross‐Sectional Study
Baskaran N, Narang T, Goyal M, et al. International Journal of Dermatology. Wiley. 2025.

Barriers to effective foot care: A mixed-methods assessment among persons with leprosy-related foot disabilities living in a leprosy colony in Bankura, West Bengal
Seth S, Kundu MK, Roy S, et al. Indian Journal of Dermatology, Venereology and Leprology. Scientific Scholar. 2025.

Exploration of tongue dorsum sampling to support clinical diagnosis of leprosy patients in the Comoros: A cross-sectional study
Krausser L, Van Nieuwenhove M, Attoumani N, et al. PLOS Neglected Tropical Diseases. Public Library of Science (PLoS). 2025; 19 (9): 1-13.

Epidemiological, Clinical and Bacteriological Profile of Leprosy in Children at the Dermatology University Hospital of Bamako
Karabinta Y. Journal of Dermatology Research. Athenaeum Scientific Publishers. 2025.

The The Effect of Psychosocial Support on Healing Time in Leprosy Survivors
Achmad LN, Tangdialla MPI, Halim A. KESANS: International Journal of Health and Science. Rifa Institute. 2025; 4 (12): 1098-1108.

Resistance to anti-leprosy drugs in multi-bacillary leprosy patients: The need for transformative action
Jindal R, Singh I, Goyal D, et al. Indian Journal of Dermatology, Venereology and Leprology. Scientific Scholar. 2025.

Breast Involvement in Leprosy: An Overlooked Clinical Manifestation in Women's Health
Haider R, Das G, Ahmed Z. WebLog Journal of Public Health and Epidemiology. 2025.

A molecular perspective on leprosy : advancing diagnostics and RNA stability, and exploring host susceptibility and potential reservoirs
Krausser L. University of Antwerp. 2025.

Clinical, therapeutic, and stigma-related challenges in leprosy and the emerging role of apremilast in managing leprosy reactions
Gayoso Cantero D, Fernández-González P, Chamorro-Tojeiro S, et al. Travel Medicine and Infectious Disease. Elsevier BV. 2025.

A Within-Person Randomized Controlled Pilot Study to Evaluate the Ability of a Point-of-Care Artificial Intelligence–Enabled Multispectral Imaging Device to Manage Leg Ulcers in Leprosy
Puttur N, Manoj R, Bhosale K, et al. Advances in Skin & Wound Care. Ovid Technologies (Wolters Kluwer Health). 2025; 38 (9): 471-479.

Subpopulações de células B em lesões de hanseníase: desvendando a complexa interação
Froes Junior LAR, Pagliari C, Trindade MAB, et al. Anais Brasileiros de Dermatologia (Versão em Português). Elsevier BV. 2025; 100 (5): 1-9.

Doenças infecciosas negligenciadas (como hanseníase e leishmaniose): uma abordagem multiprofissional em áreas endêmicas
Nascimento MEBD, Silva NRD, Melo TMD, et al. REVISTA DELOS. Brazilian Journals. 2025; 18 (73): 1-15.

Hanseníase: uma abordagem clínica e a importância da prevenção de lesão óssea
Goifman LR, Andriani PH, Griczinski GM, et al. LUMEN ET VIRTUS. Seven Events. 2025; 16 (53): 1-9.

Case Reports

Unusual sequential type I and II reactions in lepromatous leprosy: a case report
Qi X, Huang S. Transactions of The Royal Society of Tropical Medicine and Hygiene. Oxford University Press (OUP). 2025.

Uncommon Presentation of Lepromatous Leprosy in a Nonendemic Setting: A Case Report.
Osman M, Alharby T, Alhabeeb Y, et al. Case reports in medicine. 2025

Critical influence of biological delays on leprosy transmission and its control: a case study in India
Mondal T, Mukherjee S, Roy PK. International Journal of Dynamics and Control. Springer Science and Business Media LLC. 2025.

Leprosy with dystrophy in twenty nails: Detection of acid-fast bacilli in nail biopsy
Gunawan H, Hidayah RMN, Ruchiatan K, et al. Journal of Infection and Public Health. Elsevier BV. 2025; 18 (12): 1-3.

Case Report: A case of borderline lepromatous leprosy and literature review-key clues to expand clinical diagnostic thinking.
Lu L, Wang L, Wei K, et al. Frontiers in medicine. 2025.

Lucio Phenomenon Mimicking Necrotizing Myofasciitis: A Case Report Study
Nurhidayati E, Saraswati P. JURNAL LOCUS: Penelitian dan Pengabdian. 2025.

Lucio phenomenon – a rare life threatening state of leprosy
Ransimali BGS, Ranmohottige USN, Thamilvannan N, et al. Sri Lanka Journal of Dermatology. Sri Lanka Journals Online. 2025; 24 (1): 59-62.

Role of lymph node aspiration in diagnosing lepromatous leprosy
Bansal C, Anand G, Goyal A. Annals of the National Academy of Medical Sciences (India). Scientific Scholar. 2025.

Coexistencia de infecciones micobacterianas en un paciente con fenómeno de Lucio. Reporte de caso
Gonzalez FJ, Moreira-Parra JA, Martinez-Mclanghilin NB, et al. Revista científica ciencias de la salud. Universidad del Pacifico - Paraguay. 2025.

Lepromatous Lymphadenitis: A Rare Manifestation of LeprosyDiagnosed by Fine Needle Aspiration Cytology
Chitkara F, Pannu D, Saha D, et al. Annals of Pathology and Laboratory Medicine. 2025.

Lepromatous leprosy: case report
Ramos-Aguila YDLC, Hernández-Ramos Y, Cuello-Carballo MB. South Health and Policy. AG Editor (Argentina). 2026.

Missed or misjudged? Revisiting Leprosy Through Six Cases: A Case Series of long-standing diagnostic dilemma in Patients of North India
Rawat P, Mishra R. European Journal of Cardiovascular Medicine. 2025.

Hemophagocytic Lymphohistiocytosis in Leprosy: A Rare and Life-threatening Complication
Madegowda SB, Kakrannaya MP, Kalegowda D, et al. Clinical Dermatology Review. Ovid Technologies (Wolters Kluwer Health). 2025; 9 (4): 372-374.

Type 2 Lepra Reaction with Borderline Lepromatous Leprosy
Chen Q, Liu J. Dermatology Practical & Conceptual. Mattioli1885. 2025.

Erythema Nodosum Leprosum as a Harbinger of Relapse in Multibacillary Leprosy: A Clinico-Histopathological Case Study
Benedikta Lauda , Nurrachmat Mulianto . Bioscientia Medicina : Journal of Biomedicine and Translational Research. Hanif Medisiana Publisher. 2025; 9 (12): 9939-9953.

Literature Reviews

Comparison of quality-of-life domains using WHOQOL-BREF in leprosy patients: a systematic review
Salleh FNM, Shahrom MEE, Jaimon S, et al. Malaysian Journal of Public Health Medicine. 2025.

Infrared thermography: a scoping review of its possible role in the diagnosis and follow-up of leprosy neuropathy
Wim Brandsma J, Knulst-Verlaan C, Knulst AJ, et al. Leprosy Review. Lepra. 2025; 96 (3): 1-10.

Social participation of people affected with leprosy in India: what does the literature tell us? A systematic review
Govindharaj P, Agrawal S, Ramasamy S, et al. Transactions of The Royal Society of Tropical Medicine and Hygiene. Oxford University Press (OUP). 2025.

O Cuidado ao Paciente com Hanseníase na Atenção Primária à Saúde: Revisão de Literatura
Lima J, Beserra S, Thaissa De Sousa Ribeiro A, et al. Revista Piauiense de Enfermagem (REPEn). 2025

Qualidade de Vida e Hanseníase: Desafios e Perspectivas–Uma Revisão Integrativa
Messias M, Rodrigues de Sousa T. Revista Piauiense de Enfermagem (REPEn). 2025.

News & Events

Leprosy in India: The Road to a Disease-Free Future [Hindudayashankar]

New Study Finds Leprosy in the Americas Before European Arrival [The UNN Corporation]

Case of locally-acquired leprosy confirmed [Kuam news]

Call for Papers: Leveraging AI Technologies for Discoveries and Solutions in Infectious Diseases
The IDSA journals invite proposals exploring how artificial intelligence is transforming infectious disease research, clinical care, and public health.
Deadline for submission: November 2, 2025.

Europe Pre‑Conference Event for Health Systems Global Conference 2025
Date and Location: November 19, 2025, York St John University, London Campus, Export Building, 1 Clove Cres, London E14 2BA [In-person Event]
Health Systems Global (HSG) Conferences are the premier gathering for researchers, policymakers, practitioners, and advocates to advance the field of health systems strengthening.

ASTMH 2025 Annual Meeting
Date and Location: November 9-13, 2025, Toronto, Ontario, Canada
The ASTMH Annual Meeting is the premier international forum for the exchange of scientific and clinical advances in tropical medicine, hygiene and global health. World-class research findings, clinical updates and topical discussions about the hot-button global issues from the world's brightest scientific experts and thought leaders are presented over five days.

2nd International Conference on Tropical Dermatology 11th to 14th March, 2026
The second International Conference on Tropical Dermatology (ICTD), will be held at the Shangri-La Hotel in Colombo from 11th to 14th of March 2026. This esteemed event is co-organized by the Sri Lanka College of Dermatology and Aesthetic Medicine (SLCDA) in collaboration with the Deutsche Dermatologische Gesellschaft / German Dermatological Society (DDG).

Breaking the chains: A father's love conquers leprosy stigma [World Health Organization]

Leprosy cases nearly doubled in Florida in 2025 [Herriman R. Outbreak News Today]

India National Strategic Plan 2023–2027, India leads global fight against leprosy with 98 per cent decline since 1981 [Kumar V. ORGANIZER]

Call for Nominations – K.V. Desikan Memorial Award 2026
LEPRA Society invites nominations for the 2026 KV Desikan Memorial Award: Nominations are open until 1 December 2025.

RSTMH Global Research in Progress
Date and Time: 20 November 2025, 12:00 PM - 5:00 PM (GMT+1) [Online Event]
This meeting is free to attend. Certificates of attendance will be provided after the event. Places are limited and are allocated on a first-come, first-served basis. Registration is open!

ISNTD Water (water, sanitation & hygiene and tropical diseases)
Save the date! 18 November 2025 | 8:00-16:00 UTC [TBC] [Online Event]
Annual meeting on water, sanitation, & hygiene for tropical diseases. Draft programme to follow, write to info@isntd.org for further information about sharing your research in this field.

International Conference on Economic Inclusion for Persons with Disabilities
Date and Location: 18th-19th January 2026, Dhaka, Bangladesh
The International Conference on Economic Inclusion for Persons with Disabilities will bring together academics and practitioners working on disability and economic inclusion, as well as people with disabilities and their representative organizations, policymakers, and donors.
Abstract submission deadline: 31 October 2025
Registration deadline: 4 January 2026

Links

Info Hansen - An innovative hub for knowledge sharing about Hansen's Disease

ALLF - Official website of the Association des Léprologues de Langue Française

LML - Leprosy Mailing List - a free moderated email list that allows all persons interested in leprosy to share ideas, information, experiences and questions

InfoNTD - Information on cross-cutting issues in Neglected Tropical Diseases (NTDs)

ILEP newsletter archive

GPZL newsletter subscription

WHO Goodwill Ambassador's Leprosy Bulletin

Leprosy Review

Leprosy Review Repository (1928-2001)

Fontilles Revista de Leprología

Indian Journal of Leprosy

Hansenologia Internationalis

HARP - Hansen's Disease Antimicrobial Resistance Profiles

GDPR & the Infolep newsletter

New EU data protection regulations came into force on 25 May 2018. We have been reviewing our practices with regards to the GDPR, including our privacy statement and mailing list.

Infolep sends out monthly e-mails with an overview of recent publications on leprosy and related issues. The purpose of this activity is to keep subscribers up to date.

Infolep will only process the data we have (names, email addresses) for the purpose of sending you the newsletter. We take your security seriously and will never share your contact details with anyone else.

You can update your preferences or unsubscribe from this list at any time.